Alectinib as salvage therapy for metastatic Uterine inflammatory myofibroblastic tumor (UIMT) following misdiagnosis: A case enabling definitive surgery and prolonged remission
This case highlights the significant efficacy and safety of alectinib in the management of advanced, recurrent, and aggressive UIMT, while also emphasizing the essential role of multidisciplinary management. It provides valuable insights and serves as a reference for the management of similar rare cases.
Authors
- Ting Shuang (ORCID: https://orcid.org/0000-0002-6119-6989)
- Jun Bao (ORCID: https://orcid.org/0000-0001-7389-3020)
- Xiaolin Wang (ORCID: https://orcid.org/0000-0003-4293-7523)
- Yuanyuan Wang (ORCID: https://orcid.org/0000-0003-1984-1136)
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1016/j.gore.2025.101994
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00